Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies

L Li, C Yang, Y Zhao, X Zeng, F Liu, P Fu - BMC nephrology, 2014 - Springer
Background Hyperuricemia has been reported to be associated with chronic kidney disease
(CKD). However whether an elevated serum uric acid level is an independent risk factor for …

Hyperuricemia and coronary heart disease: a systematic review and meta‐analysis

SY Kim, JP Guevara, KM Kim, HK Choi… - Arthritis Care & …, 2010 - Wiley Online Library
Objective The role of serum uric acid as an independent risk factor for cardiovascular
disease remains unclear, although hyperuricemia is associated with cardiovascular disease …

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

JS Sundy, HSB Baraf, RA Yood, NL Edwards… - Jama, 2011 - jamanetwork.com
Context Patients with chronic disabling gout refractory to conventional urate-lowering
therapy need timely treatment to control disease manifestations related to tissue urate crystal …

A europium-based MOF fluorescent probe for efficiently detecting malachite green and uric acid

LJ Han, YJ Kong, GZ Hou, HC Chen… - Inorganic …, 2020 - ACS Publications
Lanthanide (such as Tb and Eu) metal–organic frameworks (MOFs) have been widely used
in fluorescent probes because of their multiple coordination modes and brilliant …

Single-atom cobalt-based electrochemical biomimetic uric acid sensor with wide linear range and ultralow detection limit

FX Hu, T Hu, S Chen, D Wang, Q Rao, Y Liu, F Dai… - Nano-micro letters, 2021 - Springer
Uric acid (UA) detection is essential in diagnosis of arthritis, preeclampsia, renal disorder,
and cardiovascular diseases, but it is very challenging to realize the required wide detection …

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

MA Becker, HR Schumacher, LR Espinoza… - Arthritis research & …, 2010 - Springer
Introduction The purpose of this study was to compare urate-lowering (UL) efficacy and
safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA)≥ 8.0 …

Hyperuricemia and risk of stroke: a systematic review and meta‐analysis

SY Kim, JP Guevara, KM Kim, HK Choi… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To assess the association between hyperuricemia and risk of stroke incidence and
mortality because hyperuricemia is hypothesized to be a risk factor for stroke and other …

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

V Vitart, I Rudan, C Hayward, NK Gray, J Floyd… - Nature …, 2008 - nature.com
Uric acid is the end product of purine metabolism in humans and great apes, which have lost
hepatic uricase activity, leading to uniquely high serum uric acid concentrations (200–500 …

Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans

N Anzai, K Ichida, P Jutabha, T Kimura, E Babu… - Journal of biological …, 2008 - ASBMB
Hyperuricemia is a significant factor in a variety of diseases, including gout and
cardiovascular diseases. Although renal excretion largely determines plasma urate …

[HTML][HTML] Uric acid induces endothelial dysfunction by activating the HMGB1/RAGE signaling pathway

W Cai, XM Duan, Y Liu, J Yu, YL Tang, ZL Liu… - BioMed research …, 2017 - hindawi.com
Uric acid (UA) is a risk factor for endothelial dysfunction, a process in which inflammation
may play an important role. UA increases high mobility group box chromosomal protein 1 …